Paul Meeks, who ran two technology-based mutual funds in the 1990s, recalls the perks and perils of the dot-com boom and bust.» Read More
Stocks are headed for a 7 percent correction, Dennis Gartman of The Gartman Letter says.
Chesapeake Energy is higher after topping estimates, with the FMHR team. Meanwhile Rob Artnott, PIMCO All Asset Fund, says now is the time to get out of the stock market.
Investors shouldn't follow the Fed out of stocks, Josh Brown of Fusion Analytics says.
After gold plummets to hit a six-month low, its fundamentals remain strong, Rick Rule says.
There are too many opportunities around to focus on Apple stock, Joe Terranova says.
Beware a lack of conviction in the market, Gemma Godfrey of Brooks Macdonald Asset Management says.
The euro is heading in a direction that could be bearish for stocks and commodities, Joe Terranova says.
Hain Celestial CEO Irwin Simon sided with Carl Icahn over Bill Ackman in a CNBC interview on Wednesday.
"House of Cards" drew a sizable audience compared to HBO's "Girls," according to a survey by Cowen research.
Herbalife reports quarterly earnings after the closing bell. But which way is the stock likely to head?
A pop in Bank of America stock isn't enough to sell, Stephen Weiss says.
Herbalife is set to report its earnings after today's closing bell, with the FMHR traders; and Weyerhaeuser CEO Dan Fulton, discusses the U.S. housing industry.
Stocks continue to make gains, but not because of investor optimism, Josh Brown says.
Greenlight Capital's David Einhorn faces off against Apple over the tech giant's cash hoard, with CNBC's Kate Kelly.
Hedge fund manager Daniel Loeb has sold part of his long position in the nutrition company Herbalife, a source told CNBC.
Recent M&A activity makes sense, Mike Santoli of Yahoo! Finance says.
"Fast Money" pros weigh in on Apple stock after well-known money managers stake positions.
Billionaire investor Carl Icahn explained taking the opposite side of Bill Ackman's short bet on Herbalife.
Is Carl Icahn's massive bullish position in Herbalife disclosed Thursday just a personal vendetta against Bill Ackman?
Hedge fund manager Bill Ackman, who made a $1 billion bet against the stock, told CNBC he remains convinced "Herbalife is a pyramid scheme," despite Carl Icahn stake.